REVVITY, INC Number of Reportable Segments
REVVITY, INC (RVTY) reported Number of Reportable Segments of 2 segments for the 6-month period ending 2026-07-05, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-11
- REVVITY, INC number of reportable segments for the quarter ending 2026-04-05 was 2.00 segments.
- REVVITY, INC number of reportable segments for fiscal 2025 was 2.00 segments.
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 12 month |
|---|---|---|---|
| 2026-07-05 | 2.00 segments 10-Q · filed 2026-08-11 | ||
| 2026-04-05 | 2.00 segments 10-Q · filed 2026-05-12 | ||
| 2025-12-28 | 2.00 segments 10-K · filed 2026-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |